Lifeward (LFWD) FCF Margin (2015 - 2026)

Lifeward (LFWD) posted FCF Margin of 93.68% for Q1 2026, down 34.57% sequentially from 69.61% in Q4 2025, and up 1554.0% YoY from 5.66% in Q1 2025.

Lifeward (LFWD) FCF Margin (2015 - 2026) Analysis & Trends

Lifeward has reported FCF Margin for 12 years, with the latest figure at 93.68% in Q1 2026.

Quarterly FCF Margin rose 1554.0% year-over-year to 93.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.78% (up 512.0% YoY) and the FY2025 annual result came in at 76.44%, up 819.0% from the prior year.
FCF Margin declined to 93.68% in Q1 2026 per LFWD's latest filing, from 69.61% in the prior quarter.
Over five years, FCF Margin peaked at 52.6% in Q4 2024 and troughed at 651.94% in Q1 2022.
A 5-year average of 192.2% and a median of 109.22% in 2025 frame the typical range for FCF Margin.
The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 41015 bps in 2022, then soared 35098 bps in 2023.
Over 5 years, FCF Margin stood at 179.58% in 2022, then jumped by 63 bps to 66.28% in 2023, then rose by 21 bps to 52.6% in 2024, then plunged by 32 bps to 69.61% in 2025, then plunged by 35 bps to 93.68% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 93.68%, 69.61%, and 62.95% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	15.81%
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	16.07%
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	21.26%
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	23.50%
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	33.60%
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	14.10%
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	1.28%
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	5.32%
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	18.73%
10	Lifeward	20.56 Mn	11.11 Mn	2.71 Mn	-90.71%

Download Data